$ICPT Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in INTERCEPT PHARMACEUTICALS, INC.. Get notifications about new insider transactions in INTERCEPT PHARMACEUTICALS, INC. for free.

Page: < prev 1 ... 7 8 9 10 11 12 13 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 11 2014	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Sell	S	301.78	1,000	301,780	7,392	8.4 K to 7.4 K (-11.92 %)
Feb 11 2014	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Buy	M	10.40	2,000	20,800	8,392	6.4 K to 8.4 K (+31.29 %)
Feb 11 2014	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Option Exercise	M	0.00	368	0	735
Feb 11 2014	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Buy	M	0.00	368	0	2,937	2.6 K to 2.9 K (+14.32 %)
Feb 11 2014	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Option Exercise	M	0.00	324	0	649
Feb 11 2014	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Buy	M	0.00	324	0	1,735,908	1.7 M to 1.7 M (+0.02 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	21.50	2,500	53,750	8,749
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	0.00	325	0	973
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Sell	S	267.94	3,250	870,805	1,943	5.2 K to 1.9 K (-62.58 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	M	21.50	2,500	53,750	5,193	2.7 K to 5.2 K (+92.83 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	M	0.00	325	0	2,693	2.4 K to 2.7 K (+13.72 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Option Exercise	M	31.90	5,625	179,438	16,875
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	283.90	250	70,975	10,708	11 K to 10.7 K (-2.28 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	280.00	125	35,000	10,958	11.1 K to 11 K (-1.13 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	274.00	50	13,700	11,083	11.1 K to 11.1 K (-0.45 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	265.00	250	66,250	11,133	11.4 K to 11.1 K (-2.20 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	264.00	250	66,000	11,383	11.6 K to 11.4 K (-2.15 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	263.00	250	65,750	11,633	11.9 K to 11.6 K (-2.10 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	262.00	250	65,500	11,883	12.1 K to 11.9 K (-2.06 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	260.00	500	130,000	12,133	12.6 K to 12.1 K (-3.96 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	258.30	500	129,150	12,633	13.1 K to 12.6 K (-3.81 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	257.27	750	192,950	13,133	13.9 K to 13.1 K (-5.40 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	256.00	500	128,000	13,883	14.4 K to 13.9 K (-3.48 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	255.00	500	127,500	14,383	14.9 K to 14.4 K (-3.36 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	253.63	1,150	291,675	14,883	16 K to 14.9 K (-7.17 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	251.55	300	75,465	16,033	16.3 K to 16 K (-1.84 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Buy	M	31.90	5,625	179,438	16,333	10.7 K to 16.3 K (+52.53 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Option Exercise	M	8.67	10,000	86,667	240,960
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Sell	S	273.68	10,000	2,736,767	430,298	440.3 K to 430.3 K (-2.27 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Buy	M	8.67	10,000	86,667	440,298	430.3 K to 440.3 K (+2.32 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Option Exercise	M	2.89	12,850	37,122	13,111
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Option Exercise	M	2.89	8,653	24,998	0
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Gift	G	0.00	7,840	0	430,298	438.1 K to 430.3 K (-1.79 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Buy	M	2.89	12,850	37,122	438,138	425.3 K to 438.1 K (+3.02 %)
Jan 17 2014	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Buy	M	2.89	8,653	24,998	425,288	416.6 K to 425.3 K (+2.08 %)
Jan 10 2014	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	8.67	3,800	32,933	50,719
Jan 10 2014	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	10.40	5,168	53,748	47,620
Jan 10 2014	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	73.09	928	67,826	8,663	9.6 K to 8.7 K (-9.68 %)
Jan 10 2014	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	71.56	4,000	286,239	9,591	13.6 K to 9.6 K (-29.43 %)
Jan 10 2014	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	8.67	3,800	32,933	13,591	9.8 K to 13.6 K (+38.81 %)
Jan 10 2014	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	10.40	5,168	53,748	9,791	4.6 K to 9.8 K (+111.79 %)
Jan 09 2014	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Option Exercise	M	10.40	1,634	16,994	8,000
Jan 09 2014	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Sell	S	67.41	1,634	110,148	6,392	8 K to 6.4 K (-20.36 %)
Jan 09 2014	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Buy	M	10.40	1,634	16,994	8,026	6.4 K to 8 K (+25.56 %)
Jan 09 2014	ICPT	INTERCEPT PHARMACE ...	TALLARIGO LORENZO	Director	Sell	S	67.41	1,839	123,967	1,640	3.5 K to 1.6 K (-52.86 %)
Jan 03 2014	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	0.00	1,623	0	12,980
Jan 03 2014	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	0.00	1,623	0	4,623	3 K to 4.6 K (+54.10 %)
Jan 03 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Option Exercise	M	0.00	1,298	0	10,385
Jan 03 2014	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Buy	M	0.00	1,298	0	10,708	9.4 K to 10.7 K (+13.79 %)
Jan 03 2014	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Option Exercise	M	0.00	4,868	0	38,942
Jan 03 2014	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Buy	M	0.00	4,868	0	416,635	411.8 K to 416.6 K (+1.18 %)
Jan 03 2014	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Option Exercise	M	0.00	649	0	5,192
Jan 03 2014	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Buy	M	0.00	649	0	6,392	5.7 K to 6.4 K (+11.30 %)
Dec 19 2013	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Sell	S	55.53	260	14,437	2,368	2.6 K to 2.4 K (-9.89 %)
Dec 17 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Option Exercise	M	10.40	3,750	39,000	52,788
Dec 17 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Sell	S	62.11	5,016	311,550	3,000	8 K to 3 K (-62.57 %)
Dec 17 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Buy	M	10.40	3,750	39,000	8,016	4.3 K to 8 K (+87.90 %)
Nov 25 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Option Exercise	M	10.40	2,000	20,800	9,634
Nov 25 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Sell	S	51.26	380	19,477	5,743	6.1 K to 5.7 K (-6.21 %)
Nov 25 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Sell	S	50.50	1,620	81,808	6,123	7.7 K to 6.1 K (-20.92 %)
Nov 25 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Buy	M	10.40	2,000	20,800	7,743	5.7 K to 7.7 K (+34.83 %)
Nov 19 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Option Exercise	M	10.40	3,750	39,000	56,538
Nov 19 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Sell	S	48.08	4,730	227,412	4,266	9 K to 4.3 K (-52.58 %)
Nov 19 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Buy	M	10.40	3,750	39,000	8,996	5.2 K to 9 K (+71.48 %)
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Option Exercise	M	0.00	368	0	1,103
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Buy	M	0.00	368	0	2,569	2.2 K to 2.6 K (+16.72 %)
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Option Exercise	M	0.00	325	0	973
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Buy	M	0.00	325	0	1,980	1.7 K to 2 K (+19.64 %)
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Option Exercise	M	0.00	325	0	973
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Sell	S	49.01	100	4,901	2,120	2.2 K to 2.1 K (-4.50 %)
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Sell	S	48.81	62	3,026	2,220	2.3 K to 2.2 K (-2.72 %)
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Buy	M	0.00	325	0	2,282	2 K to 2.3 K (+16.61 %)
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	TALLARIGO LORENZO	Director	Option Exercise	M	0.00	368	0	1,103
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	TALLARIGO LORENZO	Director	Buy	M	0.00	368	0	3,479	3.1 K to 3.5 K (+11.83 %)
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	Fundaro Paolo	Director	Option Exercise	M	0.00	325	0	973
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	Fundaro Paolo	Director	Buy	M	0.00	325	0	1,655	1.3 K to 1.7 K (+24.44 %)
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Option Exercise	M	0.00	325	0	973
Nov 12 2013	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Buy	M	0.00	325	0	1,735,584	1.7 M to 1.7 M (+0.02 %)
Oct 23 2013	ICPT	INTERCEPT PHARMACE ...	Genextra S.p.A.	10% Owner	Sell	S	62.50	124,912	7,807,000	5,938,890	6.1 M to 5.9 M (-2.06 %)
Oct 23 2013	ICPT	INTERCEPT PHARMACE ...	Micheli Francesco	10% Owner	Sell	S	62.50	124,912	7,807,000	5,938,890	6.1 M to 5.9 M (-2.06 %)
Oct 23 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Option Exercise	M	10.40	2,000	20,800	11,634
Oct 23 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Sell	S	55.51	2,000	111,027	5,743	7.7 K to 5.7 K (-25.83 %)
Oct 23 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Buy	M	10.40	2,000	20,800	7,743	5.7 K to 7.7 K (+34.83 %)
Oct 23 2013	ICPT	INTERCEPT PHARMACE ...	TALLARIGO LORENZO	Director	Sell	S	62.50	124,912	7,807,000	5,938,890	6.1 M to 5.9 M (-2.06 %)
Oct 23 2013	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	62.50	40,088	2,505,500	1,734,934	1.8 M to 1.7 M (-2.26 %)
Oct 23 2013	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	62.50	40,088	2,505,500	1,735,259	1.8 M to 1.7 M (-2.26 %)
Oct 21 2013	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	0.00	324	0	1,298
Oct 21 2013	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	M	0.00	324	0	2,628	2.3 K to 2.6 K (+14.06 %)
Oct 17 2013	ICPT	INTERCEPT PHARMACE ...	TALLARIGO LORENZO	Director	Sell	S	62.50	1,123,415	70,213,438	6,063,802	7.2 M to 6.1 M (-15.63 %)
Oct 17 2013	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	62.50	376,585	23,536,563	1,775,022	2.2 M to 1.8 M (-17.50 %)
Oct 17 2013	ICPT	INTERCEPT PHARMACE ...	Micheli Francesco	10% Owner	Sell	S	62.50	1,123,415	70,213,438	6,063,802	7.2 M to 6.1 M (-15.63 %)
Oct 17 2013	ICPT	INTERCEPT PHARMACE ...	Genextra S.p.A.	10% Owner	Sell	S	62.50	1,123,415	70,213,438	6,063,802	7.2 M to 6.1 M (-15.63 %)
Oct 17 2013	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	62.50	376,585	23,536,563	1,775,347	2.2 M to 1.8 M (-17.50 %)
Oct 11 2013	ICPT	INTERCEPT PHARMACE ...	TALLARIGO LORENZO	Director	Option Exercise	M	0.00	1,471	0	1,471
Oct 11 2013	ICPT	INTERCEPT PHARMACE ...	TALLARIGO LORENZO	Director	Buy	M	0.00	1,471	0	3,111	1.6 K to 3.1 K (+89.70 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Sell	S	75.00	71	5,325	1,957	2 K to 2 K (-3.50 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Sell	S	74.89	100	7,489	2,028	2.1 K to 2 K (-4.70 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Sell	S	74.77	100	7,477	2,128	2.2 K to 2.1 K (-4.49 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Sell	S	74.25	100	7,425	2,228	2.3 K to 2.2 K (-4.30 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Sell	S	73.57	100	7,357	2,328	2.4 K to 2.3 K (-4.12 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Sell	S	72.64	100	7,264	2,428	2.5 K to 2.4 K (-3.96 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Sell	S	69.26	100	6,926	2,528	2.6 K to 2.5 K (-3.81 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Option Exercise	M	0.00	4,867	0	43,810
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Buy	M	0.00	4,867	0	406,899	402 K to 406.9 K (+1.21 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Option Exercise	M	10.40	3,750	39,000	60,288
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Option Exercise	M	0.00	1,622	0	14,603
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Sell	S	73.10	642	46,930	5,246	5.9 K to 5.2 K (-10.90 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Sell	S	74.60	600	44,760	5,888	6.5 K to 5.9 K (-9.25 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Sell	S	73.02	1,177	85,943	6,488	7.7 K to 6.5 K (-15.36 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Sell	S	72.02	1,973	142,087	7,665	9.6 K to 7.7 K (-20.47 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Buy	M	10.40	3,750	39,000	9,638	5.9 K to 9.6 K (+63.69 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Buy	M	0.00	1,622	0	5,888	4.3 K to 5.9 K (+38.02 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Option Exercise	M	0.00	1,298	0	11,683
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Buy	M	0.00	1,298	0	9,410	8.1 K to 9.4 K (+16.00 %)
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Option Exercise	M	0.00	649	0	5,841
Oct 03 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Buy	M	0.00	649	0	5,743	5.1 K to 5.7 K (+12.74 %)
Sep 20 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Option Exercise	M	10.40	2,000	20,800	13,634
Sep 20 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Sell	S	61.07	2,000	122,134	5,094	7.1 K to 5.1 K (-28.19 %)
Sep 20 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Buy	M	10.40	2,000	20,800	7,094	5.1 K to 7.1 K (+39.26 %)
Sep 18 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Option Exercise	M	9.82	12,500	122,779	20,911
Sep 18 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Option Exercise	M	9.82	12,500	122,779	0
Sep 18 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Sell	S	52.00	25,000	1,300,000	402,032	427 K to 402 K (-5.85 %)
Sep 18 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Buy	M	9.82	12,500	122,779	427,032	414.5 K to 427 K (+3.02 %)
Sep 18 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Buy	M	9.82	12,500	122,779	414,532	402 K to 414.5 K (+3.11 %)
Sep 18 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Option Exercise	M	10.40	3,750	39,000	64,038
Sep 18 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Sell	S	49.20	5,016	246,784	4,266	9.3 K to 4.3 K (-54.04 %)
Sep 18 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Buy	M	10.40	3,750	39,000	9,282	5.5 K to 9.3 K (+67.79 %)
Sep 13 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Option Exercise	M	9.82	7,694	75,573	33,411
Sep 13 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Option Exercise	M	9.82	3,906	38,366	12,500
Sep 13 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Option Exercise	M	9.82	900	8,840	16,406
Sep 13 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Sell	S	49.05	9,804	480,886	402,032	411.8 K to 402 K (-2.38 %)
Sep 13 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Sell	S	48.51	1,796	87,124	411,836	413.6 K to 411.8 K (-0.43 %)
Sep 13 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Buy	M	9.82	7,694	75,573	413,632	405.9 K to 413.6 K (+1.90 %)
Sep 13 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Buy	M	9.82	3,906	38,366	405,938	402 K to 405.9 K (+0.97 %)
Sep 13 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Sell	S	49.65	900	44,684	402,032	402.9 K to 402 K (-0.22 %)
Sep 13 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Buy	M	9.82	900	8,840	402,932	402 K to 402.9 K (+0.22 %)
Sep 06 2013	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Sell	S	46.43	600	27,856	2,201	2.8 K to 2.2 K (-21.42 %)
Aug 22 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Option Exercise	M	10.40	2,000	20,800	15,634
Aug 22 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Sell	S	44.18	2,000	88,360	5,094	7.1 K to 5.1 K (-28.19 %)
Aug 22 2013	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Buy	M	10.40	2,000	20,800	7,094	5.1 K to 7.1 K (+39.26 %)
Aug 16 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Option Exercise	M	10.40	3,750	39,000	67,788
Aug 16 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Sell	S	45.04	4,754	214,120	2,532	7.3 K to 2.5 K (-65.25 %)
Aug 16 2013	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO & EVP - Develop ...	Buy	M	10.40	3,750	39,000	7,286	3.5 K to 7.3 K (+106.05 %)
Aug 13 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Option Exercise	M	0.00	325	0	1,298
Aug 13 2013	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Buy	M	0.00	325	0	2,628	2.3 K to 2.6 K (+14.11 %)
Aug 13 2013	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Option Exercise	M	0.00	325	0	1,298
Aug 13 2013	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Buy	M	0.00	325	0	1,655	1.3 K to 1.7 K (+24.44 %)
Aug 13 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Option Exercise	M	9.82	12,500	122,779	17,306
Aug 13 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Sell	S	45.98	12,500	574,724	402,032	414.5 K to 402 K (-3.02 %)
Aug 13 2013	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	President and CEO	Buy	M	9.82	12,500	122,779	414,532	402 K to 414.5 K (+3.11 %)

Page: < prev 1 ... 7 8 9 10 11 12 13 next >